Home > Insider Trading > Filing (0001479290-18-000048)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225755	P Lauren Silvernail	C/O Revance Therapeutics, Inc. 7555 Gateway Boulevard Newark CA 94560	Cfo, Cbo & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-13	25,867	$8.70	98,821	No	4	M	Direct
Common Stock	Disposition	2018-03-13	25,867	$34.50	72,954	No	4	S	Direct
Common Stock	Disposition	2018-03-15	1,152	$31.65	71,802	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy)	Acquisiton	2018-03-13	25,867	$0.00	25,867	$8.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-05-23	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mrs. Silvernail.
Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2018, to satisfy tax withholding obligations that arose in connection with the vesting of a 2016 Restricted Stock Award ("RSA") for 10,000 shares. The RSA vests in three (3) equal annual installments from March 15, 2016, subject to Mrs. Silvernail's Continuous Service (as defined in the Plan) on each vesting date.
The Option became fully vested as of March 18, 2017.